Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The FDA said Chantix and Zyban will carry the warnings to alert consumers to the risks of depression and suicidal thoughts when using the drugs. The drugs also have been reported to cause changes in behavior, hostility and agitation in users, whether users had a history of psychiatric illness or not. In many cases, side effects started shortly after use began and ended when the medication was stopped.

   

Today in Popular Press...keeping you current

Potential new heart attack biomarker uncovered
EurekAlert, 12/11/09

Pathological gambling may be successfully treated with medications for substance addiction
EurekAlert, 12/11/09

New model of skin cancer provides insights on second-most common type of cancer
EurekAlert, 12/11/09